Jefferies Group’s CVS Health CVS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | $288K | Sell |
3,019
-4,250
| -58% | -$421K | ﹤0.01% | 1245 |
|
|
2022
Q2 | $674K | Sell |
7,269
-69,500
| -91% | -$6.78M | 0.01% | 909 |
|
|
2022
Q1 | $7.77M | Buy |
76,769
+73,485
| +2,238% | +$7.72M | 0.05% | 292 |
|
|
2021
Q4 | $339K | Sell |
3,284
-42,130
| -93% | -$3.89M | ﹤0.01% | 1275 |
|
|
2021
Q3 | $3.85M | Buy |
+45,414
| New | +$3.8M | 0.03% | 515 |
|
|
2021
Q1 | – | Sell |
-147,349
| Closed | -$10.1M | – | 1693 |
|
|
2020
Q4 | $10.1M | Buy |
147,349
+39,549
| +37% | +$2.57M | 0.08% | 213 |
|
|
2020
Q3 | $6.3M | Sell |
107,800
-84,693
| -44% | -$5.27M | 0.07% | 236 |
|
|
2020
Q2 | $12.5K | Sell |
192,493
-6,305
| -3% | -$397K | 0.15% | 105 |
|
|
2020
Q1 | $11.8M | Buy |
198,798
+39,176
| +25% | +$2.62M | 0.13% | 131 |
|
|
2019
Q4 | $11.9M | Buy |
159,622
+77,173
| +94% | +$5.42M | 0.09% | 185 |
|
|
2019
Q3 | $5.2M | Sell |
82,449
-53,386
| -39% | -$3.16M | 0.04% | 497 |
|
|
2019
Q2 | $7.4M | Sell |
135,835
-156,659
| -54% | -$8.44M | 0.05% | 313 |
|
|
2019
Q1 | $15.8M | Buy |
292,494
+183,829
| +169% | +$11.3M | 0.13% | 116 |
|
|
2018
Q4 | $7.12M | Sell |
108,665
-7,008
| -6% | -$523K | 0.06% | 290 |
|
|
2018
Q3 | $9.11M | Buy |
115,673
+22,777
| +25% | +$1.63M | 0.06% | 305 |
|
|
2018
Q2 | $5.98M | Sell |
92,896
-29,512
| -24% | -$1.94M | 0.03% | 449 |
|
|
2018
Q1 | $7.62M | Buy |
122,408
+17,796
| +17% | +$1.28M | 0.04% | 327 |
|
|
2017
Q4 | $7.58M | Buy |
104,612
+71,344
| +214% | +$5.19M | 0.04% | 410 |
|
|
2017
Q3 | $2.71M | Buy |
33,268
+3,347
| +11% | +$265K | 0.02% | 795 |
|
|
2017
Q2 | $2.41M | Sell |
29,921
-42,429
| -59% | -$3.35M | 0.02% | 867 |
|
|
2017
Q1 | $5.68M | Buy |
72,350
+62,058
| +603% | +$4.95M | 0.04% | 452 |
|
|
2016
Q4 | $812K | Sell |
10,292
-189,424
| -95% | -$15.3M | ﹤0.01% | 1382 |
|
|
2016
Q3 | $17.8M | Buy |
199,716
+123,079
| +161% | +$11.6M | 0.09% | 172 |
|
|
2016
Q2 | $7.34M | Buy |
76,637
+73,612
| +2,433% | +$7.34M | 0.03% | 368 |
|
|
2016
Q1 | $314K | Sell |
3,025
-48,300
| -94% | -$4.7M | ﹤0.01% | 1655 |
|
|
2015
Q4 | $5.02M | Sell |
51,325
-99,343
| -66% | -$9.73M | 0.03% | 469 |
|
|
2015
Q3 | $14.5M | Buy |
150,668
+97,385
| +183% | +$10.2M | 0.08% | 181 |
|
|
2015
Q2 | $5.59M | Buy |
53,283
+24,543
| +85% | +$2.51M | 0.03% | 473 |
|
|
2015
Q1 | $2.97M | Buy |
28,740
+21,173
| +280% | +$2.14M | 0.02% | 610 |
|
|
2014
Q4 | $729K | Sell |
7,567
-52,330
| -87% | -$4.61M | ﹤0.01% | 1108 |
|
|
2014
Q3 | $4.77M | Sell |
59,897
-6,358
| -10% | -$501K | 0.03% | 440 |
|
|
2014
Q2 | $4.99M | Buy |
66,255
+30,687
| +86% | +$2.32M | 0.04% | 352 |
|
|
2014
Q1 | $2.66M | Buy |
35,568
+28,866
| +431% | +$2.04M | 0.03% | 514 |
|
|
2013
Q4 | $480K | Sell |
6,702
-55,286
| -89% | -$3.55M | ﹤0.01% | 1168 |
|
|
2013
Q3 | $3.52M | Buy |
61,988
+36,832
| +146% | +$2.19M | 0.03% | 415 |
|
|
2013
Q2 | $1.44M | Buy |
+25,156
| New | +$1.46M | 0.02% | 639 |
|
Other funds holding CVS
Jefferies Group's CVS Position: Q3 2022 in Review
Jefferies Group reduced its CVS Health (CVS) stake by 58% in Q3 2022, selling an estimated $421K and leaving 3,019 shares worth $288K. The position accounts for ﹤0.01% of the portfolio, ranked #1245.
Jefferies Group first reported a position in CVS in Q2 2013 and has held it in 36 quarters since. The position peaked at $17.8M in Q3 2016. 2,324 funds tracked by Wall St. Rank hold CVS as of Q3 2022.
- Jefferies Group held 3,019 shares of CVS Health worth $288K as of Q3 2022.
- Jefferies Group sold 4,250 CVS Health shares in Q3 2022, an estimated $421K.
- CVS Health made up ﹤0.01% of Jefferies Group's portfolio in Q3 2022, its #1245 holding.
- Jefferies Group first reported a position in CVS Health in Q2 2013 and has held it in 36 quarters since.
- Jefferies Group's CVS Health position peaked at $17.8M in Q3 2016.
- 2,324 funds tracked by Wall St. Rank held CVS Health as of Q3 2022.
Based on Jefferies Group's 13F filing for Q3 2022, filed 14 Nov 2022.